The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway

Tatsuya Ozawa, Norie Araki, Shunji Yunoue, Hiroshi Tokuo, Liping Feng, Siriporn Patrakitkomjorn, Toshihiro Hara, Yasuko Ichikawa, Kunio Matsumoto, Kiyotaka Fuji, Hideyuki Saya

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Neurofibromin is a neurofibromatosis type 1 (NF1) tumor suppressor gene product with a domain that acts as a GTPase-activating protein and functions, in part, as a negative regulator of Ras. Loss of neurofibromin expression in NF1 patients is associated with elevated Ras activity and increased cell proliferation, predisposing to a variety of tumors of the peripheral and central nervous systems. We show here, using the small interfering RNA (siRNA) technique, that neurofibromin dynamically regulates actin cytoskeletal reorganization, followed by enhanced cell motility and gross cell aggregation in Matrigel matrix. NF1 siRNA induces characteristic morphological changes, such as excessive actin stress fiber formation, with elevated negative phosphorylation levels of cofilin, which regulates actin cytoskeletal reorganization by depolymerizing and severing actin filaments. We found that the elevated phosphorylation of cofilin in neurofibromin-depleted cells is promoted by activation of a Rho-ROCK-LIMK2 pathway, which requires Ras activation but is not transduced through three major Ras-mediated downstream pathways via Raf, phosphatidylinositol 3-kinase, and RalGEF. In addition, the exogenous expression of the NF1-GTPase-activating protein-related domain suppressed the NF1 siRNA-induced phenotypes. Neurofibromin was demonstrated to play a significant role in the machinery regulating cell proliferation and in actin cytoskeletal reorganization, which affects cell motility and adhesion. These findings may explain, in part, the mechanism of multiple neurofibroma formation in NF1 patients.

Original languageEnglish
Pages (from-to)39524-39533
Number of pages10
JournalJournal of Biological Chemistry
Volume280
Issue number47
DOIs
Publication statusPublished - 2005 Nov 25
Externally publishedYes

Fingerprint

Neurofibromin 1
Actin Depolymerizing Factors
Neurofibromatosis 1
Actin Cytoskeleton
Cell Movement
Actins
Small Interfering RNA
GTPase-Activating Proteins
Phosphorylation
Cell proliferation
Tumors
Chemical activation
Phosphatidylinositol 3-Kinase
Cell Proliferation
Nervous System Neoplasms
Neurology
Cell Aggregation
Stress Fibers
Neurofibromatoses
Peripheral Nervous System

ASJC Scopus subject areas

  • Biochemistry

Cite this

The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. / Ozawa, Tatsuya; Araki, Norie; Yunoue, Shunji; Tokuo, Hiroshi; Feng, Liping; Patrakitkomjorn, Siriporn; Hara, Toshihiro; Ichikawa, Yasuko; Matsumoto, Kunio; Fuji, Kiyotaka; Saya, Hideyuki.

In: Journal of Biological Chemistry, Vol. 280, No. 47, 25.11.2005, p. 39524-39533.

Research output: Contribution to journalArticle

Ozawa, T, Araki, N, Yunoue, S, Tokuo, H, Feng, L, Patrakitkomjorn, S, Hara, T, Ichikawa, Y, Matsumoto, K, Fuji, K & Saya, H 2005, 'The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway', Journal of Biological Chemistry, vol. 280, no. 47, pp. 39524-39533. https://doi.org/10.1074/jbc.M503707200
Ozawa, Tatsuya ; Araki, Norie ; Yunoue, Shunji ; Tokuo, Hiroshi ; Feng, Liping ; Patrakitkomjorn, Siriporn ; Hara, Toshihiro ; Ichikawa, Yasuko ; Matsumoto, Kunio ; Fuji, Kiyotaka ; Saya, Hideyuki. / The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 47. pp. 39524-39533.
@article{314d2ec69cf1436c81ff0feb3864cecc,
title = "The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway",
abstract = "Neurofibromin is a neurofibromatosis type 1 (NF1) tumor suppressor gene product with a domain that acts as a GTPase-activating protein and functions, in part, as a negative regulator of Ras. Loss of neurofibromin expression in NF1 patients is associated with elevated Ras activity and increased cell proliferation, predisposing to a variety of tumors of the peripheral and central nervous systems. We show here, using the small interfering RNA (siRNA) technique, that neurofibromin dynamically regulates actin cytoskeletal reorganization, followed by enhanced cell motility and gross cell aggregation in Matrigel matrix. NF1 siRNA induces characteristic morphological changes, such as excessive actin stress fiber formation, with elevated negative phosphorylation levels of cofilin, which regulates actin cytoskeletal reorganization by depolymerizing and severing actin filaments. We found that the elevated phosphorylation of cofilin in neurofibromin-depleted cells is promoted by activation of a Rho-ROCK-LIMK2 pathway, which requires Ras activation but is not transduced through three major Ras-mediated downstream pathways via Raf, phosphatidylinositol 3-kinase, and RalGEF. In addition, the exogenous expression of the NF1-GTPase-activating protein-related domain suppressed the NF1 siRNA-induced phenotypes. Neurofibromin was demonstrated to play a significant role in the machinery regulating cell proliferation and in actin cytoskeletal reorganization, which affects cell motility and adhesion. These findings may explain, in part, the mechanism of multiple neurofibroma formation in NF1 patients.",
author = "Tatsuya Ozawa and Norie Araki and Shunji Yunoue and Hiroshi Tokuo and Liping Feng and Siriporn Patrakitkomjorn and Toshihiro Hara and Yasuko Ichikawa and Kunio Matsumoto and Kiyotaka Fuji and Hideyuki Saya",
year = "2005",
month = "11",
day = "25",
doi = "10.1074/jbc.M503707200",
language = "English",
volume = "280",
pages = "39524--39533",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "47",

}

TY - JOUR

T1 - The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway

AU - Ozawa, Tatsuya

AU - Araki, Norie

AU - Yunoue, Shunji

AU - Tokuo, Hiroshi

AU - Feng, Liping

AU - Patrakitkomjorn, Siriporn

AU - Hara, Toshihiro

AU - Ichikawa, Yasuko

AU - Matsumoto, Kunio

AU - Fuji, Kiyotaka

AU - Saya, Hideyuki

PY - 2005/11/25

Y1 - 2005/11/25

N2 - Neurofibromin is a neurofibromatosis type 1 (NF1) tumor suppressor gene product with a domain that acts as a GTPase-activating protein and functions, in part, as a negative regulator of Ras. Loss of neurofibromin expression in NF1 patients is associated with elevated Ras activity and increased cell proliferation, predisposing to a variety of tumors of the peripheral and central nervous systems. We show here, using the small interfering RNA (siRNA) technique, that neurofibromin dynamically regulates actin cytoskeletal reorganization, followed by enhanced cell motility and gross cell aggregation in Matrigel matrix. NF1 siRNA induces characteristic morphological changes, such as excessive actin stress fiber formation, with elevated negative phosphorylation levels of cofilin, which regulates actin cytoskeletal reorganization by depolymerizing and severing actin filaments. We found that the elevated phosphorylation of cofilin in neurofibromin-depleted cells is promoted by activation of a Rho-ROCK-LIMK2 pathway, which requires Ras activation but is not transduced through three major Ras-mediated downstream pathways via Raf, phosphatidylinositol 3-kinase, and RalGEF. In addition, the exogenous expression of the NF1-GTPase-activating protein-related domain suppressed the NF1 siRNA-induced phenotypes. Neurofibromin was demonstrated to play a significant role in the machinery regulating cell proliferation and in actin cytoskeletal reorganization, which affects cell motility and adhesion. These findings may explain, in part, the mechanism of multiple neurofibroma formation in NF1 patients.

AB - Neurofibromin is a neurofibromatosis type 1 (NF1) tumor suppressor gene product with a domain that acts as a GTPase-activating protein and functions, in part, as a negative regulator of Ras. Loss of neurofibromin expression in NF1 patients is associated with elevated Ras activity and increased cell proliferation, predisposing to a variety of tumors of the peripheral and central nervous systems. We show here, using the small interfering RNA (siRNA) technique, that neurofibromin dynamically regulates actin cytoskeletal reorganization, followed by enhanced cell motility and gross cell aggregation in Matrigel matrix. NF1 siRNA induces characteristic morphological changes, such as excessive actin stress fiber formation, with elevated negative phosphorylation levels of cofilin, which regulates actin cytoskeletal reorganization by depolymerizing and severing actin filaments. We found that the elevated phosphorylation of cofilin in neurofibromin-depleted cells is promoted by activation of a Rho-ROCK-LIMK2 pathway, which requires Ras activation but is not transduced through three major Ras-mediated downstream pathways via Raf, phosphatidylinositol 3-kinase, and RalGEF. In addition, the exogenous expression of the NF1-GTPase-activating protein-related domain suppressed the NF1 siRNA-induced phenotypes. Neurofibromin was demonstrated to play a significant role in the machinery regulating cell proliferation and in actin cytoskeletal reorganization, which affects cell motility and adhesion. These findings may explain, in part, the mechanism of multiple neurofibroma formation in NF1 patients.

UR - http://www.scopus.com/inward/record.url?scp=28244469687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28244469687&partnerID=8YFLogxK

U2 - 10.1074/jbc.M503707200

DO - 10.1074/jbc.M503707200

M3 - Article

VL - 280

SP - 39524

EP - 39533

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 47

ER -